Search

everythinglearnresearchcommunity

for

Search:↓

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

GnRH treatment can reduce breast cancer cell invasion.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

A portable imaging system shows promise for diagnosing skin diseases and checking laser treatment effects.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

MVP treatment is effective and safe for recurrent breast cancer.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Mitotane changes steroid breakdown, affecting cortisol availability.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

New biomarkers and targets for breast cancer treatment were identified to help prevent relapse and metastasis.

Chemical treatments on bleached black hair change its internal structure by breaking and reforming bonds, and treatments with hydrolyzed eggwhite protein help repair it.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

Verilich serum effectively and safely improves hair loss treatment.

The treatment is safe and shows promise for metastatic breast cancer.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Most adverse reactions to the treatment were mild, with nausea being the most common.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.